Cohort (CHRT) Competitors GBX 1,329.19 -12.81 (-0.95%) As of 08:27 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock CHRT vs. CHG, BOE, GEC, SNR, AVON, HARL, VEL, AERO, RR, and BAShould you be buying Cohort stock or one of its competitors? The main competitors of Cohort include Chemring Group (CHG), Boeing (BOE), General Electric (GEC), Senior (SNR), Avon Protection (AVON), Harland & Wolff Group (HARL), Velocity Composites (VEL), Strat Aero (AERO), Rolls-Royce Holdings plc (RR), and BAE Systems (BA). These companies are all part of the "aerospace & defense" industry. Cohort vs. Its Competitors Chemring Group Boeing General Electric Senior Avon Protection Harland & Wolff Group Velocity Composites Strat Aero Rolls-Royce Holdings plc BAE Systems Cohort (LON:CHRT) and Chemring Group (LON:CHG) are both small-cap industrials companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability. Is CHRT or CHG a better dividend stock? Cohort pays an annual dividend of GBX 0.15 per share and has a dividend yield of 0.0%. Chemring Group pays an annual dividend of GBX 0.08 per share and has a dividend yield of 0.0%. Cohort pays out 34.7% of its earnings in the form of a dividend. Chemring Group pays out 49.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the media refer more to CHRT or CHG? In the previous week, Cohort had 3 more articles in the media than Chemring Group. MarketBeat recorded 4 mentions for Cohort and 1 mentions for Chemring Group. Chemring Group's average media sentiment score of 1.16 beat Cohort's score of 0.49 indicating that Chemring Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cohort 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Chemring Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CHRT or CHG more profitable? Cohort has a net margin of 7.56% compared to Chemring Group's net margin of 0.64%. Cohort's return on equity of 14.91% beat Chemring Group's return on equity.Company Net Margins Return on Equity Return on Assets Cohort7.56% 14.91% 5.54% Chemring Group 0.64%0.88%7.03% Which has stronger earnings & valuation, CHRT or CHG? Cohort has higher earnings, but lower revenue than Chemring Group. Cohort is trading at a lower price-to-earnings ratio than Chemring Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCohort£270.04M2.25£17.19M£0.443,003.82Chemring Group£521.30M2.92£2.18M£0.163,575.95 Which has more risk & volatility, CHRT or CHG? Cohort has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Chemring Group has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Do analysts prefer CHRT or CHG? Cohort currently has a consensus target price of GBX 1,630, suggesting a potential upside of 22.63%. Chemring Group has a consensus target price of GBX 570, suggesting a potential upside of 0.88%. Given Cohort's higher probable upside, analysts plainly believe Cohort is more favorable than Chemring Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cohort 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Chemring Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in CHRT or CHG? 46.0% of Cohort shares are owned by institutional investors. Comparatively, 68.8% of Chemring Group shares are owned by institutional investors. 28.5% of Cohort shares are owned by company insiders. Comparatively, 1.2% of Chemring Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryChemring Group beats Cohort on 9 of the 17 factors compared between the two stocks. Get Cohort News Delivered to You Automatically Sign up to receive the latest news and ratings for CHRT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHRT vs. The Competition Export to ExcelMetricCohortAerospace & Defense IndustryIndustrials SectorLON ExchangeMarket Cap£606.51M£15.65B£7.88B£2.61BDividend Yield1.17%2.60%4.57%5.28%P/E Ratio3,003.82344.34302.174,427.11Price / Sales2.2587.501,322.22100,285.88Price / Cash4.1321.4028.3627.90Price / Book4.904.974.958.81Net Income£17.19M£223.64M£791.48M£5.89B7 Day Performance-4.65%0.34%0.26%0.27%1 Month Performance4.33%11.83%5.10%2.71%1 Year Performance54.20%84.60%29.98%148.25% Cohort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHRTCohort2.7838 of 5 starsGBX 1,329.19-1.0%GBX 1,630+22.6%+52.5%£606.51M£270.04M3,003.821,243Positive NewsDividend CutCHGChemring Group1.5076 of 5 starsGBX 584.37-0.8%GBX 570-2.5%+57.3%£1.57B£521.30M3,698.532,600Dividend IncreaseGap UpBOEBoeingN/AN/AN/AN/A£1.32B£70.54B-30.77156,000Gap UpGECGeneral ElectricN/AN/AN/AN/A£1.14B£69.52B27.63125,000Gap UpSNRSenior1.1875 of 5 starsGBX 197.77-0.4%GBX 202.50+2.4%+51.1%£817.57M£986.60M-10,632.636,679News CoverageAVONAvon ProtectionN/AGBX 2,085-1.9%N/A+67.7%£617.95M£296.60M9,881.52928News CoverageDividend IncreaseHARLHarland & Wolff GroupN/AN/AN/AN/A£14.49M£86.91M-34.9081VELVelocity Composites1.5128 of 5 starsGBX 21.52+0.6%GBX 60+178.8%-32.9%£11.77M£22.70M-1,570.80102News CoverageAnalyst ForecastAEROStrat AeroN/AN/AN/AN/A£0.00N/A0.00N/AGap DownRRRolls-Royce Holdings plc3.4136 of 5 starsGBX 1,190+2.3%GBX 1,188.67-0.1%+118.4%£102.06B£18.13B43.3841,400Positive NewsInsider TradeHigh Trading VolumeBABAE Systems1.7848 of 5 starsGBX 2,059+0.6%GBX 1,976.75-4.0%+57.1%£63.75B£24.86B35.32156,000High Trading Volume Related Companies and Tools Related Companies Chemring Group Alternatives Boeing Alternatives General Electric Alternatives Senior Alternatives Avon Protection Alternatives Harland & Wolff Group Alternatives Velocity Composites Alternatives Strat Aero Alternatives Rolls-Royce Holdings plc Alternatives BAE Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CHRT) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cohort plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cohort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
